diabetes

Documents about diabetes

• 25 U.S.C. § 1621c — Diabetes prevention, treatment, and control#582466US Code (LII)
• 42 U.S.C. § 280g-14 — National diabetes prevention program#595255US Code (LII)
• 42 U.S.C. § 247b-9 — Diabetes in children and youth#595369US Code (LII)
• 42 U.S.C. § 247b-9a — Better diabetes care#595370US Code (LII)
• Comparison of Premixed Insulin With Basal-plus Insulin in Type 2 Diabetes Patients#18539ClinicalTrials.gov
• Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin in Subjects With Type 2 Diabetes (SUSTAIN - CHINA MRCT)#18556ClinicalTrials.gov
• Treatment of Morbidly Obese Adolescent With a Duodena-jejunal Liner#18567ClinicalTrials.gov
• Metformin-Dipyridamole Interaction Trial#18570ClinicalTrials.gov
• Mifepristone Effects on Glucose Intolerance in Obese/Overweight Adults#18756ClinicalTrials.gov
• Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results#18777ClinicalTrials.gov
• Comparative Glucose Clamp Study of Wockhardt's Insulin Human Regular for Injection and Actrapid, in Healthy Subjects.#18813ClinicalTrials.gov
• Micro-mobile Foot Compression and Diabetic Foot#18814ClinicalTrials.gov
• Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Insulin Aspart in Subjects With Type 1 Diabetes#18816ClinicalTrials.gov
• Special Survey for Patients With Type 1 or Type 2 Diabetes#18819ClinicalTrials.gov
• Cocoa, Polyphenols, and the Kidney in Healthy Subjects and in Subjects With Hypertension and Diabetes Mellitus#28487ClinicalTrials.gov
• Structured Diabetes Self-Management Education in Primary Care and Metabolic Control#28495ClinicalTrials.gov
• A Randomised Trial Evaluating Continuous Subcutaneous Infusion of Formulations of NN1218 and NovoLog® in Subjects With Type 1 Diabetes#28496ClinicalTrials.gov
• The Effect of Real-time Continuous Glucose Monitoring on Severe Complications to Pregnancy in Women With Diabetes#28505ClinicalTrials.gov
• A Randomised, Single Centre, Double-blind, Two-period, Cross-over Trial in Healthy Subjects Investigating the Bioequivalence Between Subcutaneous Injections of Semaglutide Produced by Two Manufacturing Processes#28532ClinicalTrials.gov
• Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes#28536ClinicalTrials.gov
• A Performance Evaluation of the Lumiradx Point of Care HbA1c Device#28544ClinicalTrials.gov
• Effect of Repaglinide and Metformin Combination Tablet or Rosiglitazone and Metformin in Fixed Dose Combination on Blood Glucose Control in Patients With Type 2 Diabetes#28552ClinicalTrials.gov
• The Effect of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin on Glycaemic Control in Subjects With Type 2 Diabetes Mellitus#28578ClinicalTrials.gov
• Comparison of NN5401 With Insulin Glargine in Insulin Naive Subjects With Type 2 Diabetes#67787ClinicalTrials.gov
• StartRIGHT: A Pilot Research Study About Diabetes Diagnosis & Treatment#67789ClinicalTrials.gov
• Management of Diabetes With Metformin In Patients With Chronic Heart Failure#67812ClinicalTrials.gov
• Developing an Adaptive Lifestyle Intervention Program in Family Medicine Clinics#67833ClinicalTrials.gov
• A Study to Compare Insulin Intensification of Biphasic Insulin Aspart 30 and Insulin Analogues (Insulin Glargine and Insulin Aspart) in Insulin naïve Type 2 Diabetic Patients#67837ClinicalTrials.gov
• Study on Periodontal Treatment in Diabetic Patients#67951ClinicalTrials.gov
• Comparing Semaglutide Administered Subcutaneously Once Daily to Semaglutide Administered Subcutaneously Once Weekly#121229ClinicalTrials.gov
• Identification and Characterization of Diabetes in Low-resource Populations#121235ClinicalTrials.gov
• Behavioral Economics in Provider Incentive Design#121236ClinicalTrials.gov
• Dexcom Continuous Glucose Monitoring in Long-term Care#121240ClinicalTrials.gov
• Improving Care for Patients With Diabetes and Poor Numeracy Skills#121259ClinicalTrials.gov
• ST of TN-Salud Con La Familia: Prevent Onset of Ped Obesity#121262ClinicalTrials.gov
• The Occurence of Pancreatic Cancer Studied in Association With Newly Diagnosed Diabetes in the Elderly#121266ClinicalTrials.gov
• A Study of Saxagliptin in Subjects With Type 2 Diabetes Who Have Inadequate Blood Sugar Control With Sulfonylureas#121269ClinicalTrials.gov
• Effect of Vildagliptin in Type 2 Diabetes Treated With Sulphonylurea and Metformin#121289ClinicalTrials.gov
• Investigate the Effect of Food on the Pharmacokinetics of JLP-1310 in Healthy Male Volunteers#121309ClinicalTrials.gov
• Medical Optimization of Management of Type 2 Diabetes Complicating Pregnancy (MOMPOD)#123401ClinicalTrials.gov
• Glycemic Targets for Pregnant Women With GDM and T2DM#123411ClinicalTrials.gov
• Changes in Mitochondrial Uncoupling Protein 2 (UCP2) Messenger RNA(mRNA) in Type 2 Diabetes (T2DM) Patients#123427ClinicalTrials.gov
• In Vitro Demonstration of Direct Platelet-Related Effects of PCSK9 Enzyme#123431ClinicalTrials.gov
• Refinement and Testing of Recruitment Methodology for Behavioral Medication Adherence Interventions Using Behavioral Science-based Approaches#123633ClinicalTrials.gov
• Stem Cell Mobilization With Plerixafor in Diabetic vs Control Subjects#123642ClinicalTrials.gov
• To Compare the Pharmacokinetics and Pharmacodynamics of HR20014, INS068 and INS062 After Single Subcutaneous Injection in Healthy Subjects#329448ClinicalTrials.gov
• Postoperative Hyperbaric Oxygen Treatments to Reduce Complications in Diabetic Patients Undergoing Vascular Surgery#329472ClinicalTrials.gov
• The Effects of Alpha-1 Antitrypsin (AAT) on the Progression of Type 1 Diabetes#332677ClinicalTrials.gov
• Effect of Macronutrient Supplementation on Glycemic Index of Pita Bread#332684ClinicalTrials.gov
• Development of A Novel Anti-Hyperglycemic Agent#332688ClinicalTrials.gov

Related topics